About Us

Impact Biomedical drives mission-oriented discovery and development to pursue new products and treatment options in specialty biopharmaceuticals and consumer healthcare.

Our biopharmaceutical technologies have potential to advance treatment in oncology, neurology, and immunology. Consumer efforts include naturally based sugar alternatives, fragrances and insect repellents, as well antibacterial, antiviral, and antimicrobial technologies. A true spirit and desire of continuous improvement in healthcare result in continuous discovery of new technologies.

Core Technologies

3F™ (Functional Fragrance Formulation) is a unique formulation of specialized ingredients (e.g. terpenes) from botanical sources with demonstrated effect as an insect repellent and an antimicrobial..

Equivir technology is a novel blend of FDA Generally Recognized as Safe (GRAS) eligible polyphenols that have proven antiviral effects with additional potential applications such as medication or supplements..

LineBacker is a platform electrophilically enhanced polyphenols to induce potency, efficacy, and bioavailability, without compromising safety standards..

Executive Officers

Frank D. Heuszel, Esq.

CEO

Mark Suseck

COO

Todd Macko

CFO

Board of Directors

Frank D. Heuszel, Esq.

Chairman of the Board